117 related articles for article (PubMed ID: 11051036)
21. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
[TBL] [Abstract][Full Text] [Related]
23. Kinetics and dose of daily hemofiltration.
Yamashita AC; Kawanishi H
Blood Purif; 2004; 22 Suppl 2():14-9. PubMed ID: 15655317
[TBL] [Abstract][Full Text] [Related]
24. Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study.
Altieri P; Sorba G; Bolasco P; Ledebo I; Ganadu M; Ferrara R; Menneas A; Asproni E; Casu D; Passaghe M; Sau G; Cadinu F;
J Nephrol; 2004; 17(3):414-22. PubMed ID: 15365963
[TBL] [Abstract][Full Text] [Related]
25. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.
Gerdemann A; Wagner Z; Solf A; Bahner U; Heidland A; Vienken J; Schinzel R
Nephrol Dial Transplant; 2002 Jun; 17(6):1045-9. PubMed ID: 12032195
[TBL] [Abstract][Full Text] [Related]
26. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
[TBL] [Abstract][Full Text] [Related]
27. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
[TBL] [Abstract][Full Text] [Related]
28. On-line monitoring and convective treatment modalities: short-term advantages.
Locatelli F; Manzoni C; Di Filippo S; Andrulli S
Nephrol Dial Transplant; 1999; 14 Suppl 3():92-7. PubMed ID: 10382988
[TBL] [Abstract][Full Text] [Related]
29. Quantitative analysis of convective dose in hemofiltration and hemodiafiltration: "predilution" vs. "postdilution" reinfusion.
Colussi G; Frattini G
Hemodial Int; 2007 Jan; 11(1):76-85. PubMed ID: 17257360
[TBL] [Abstract][Full Text] [Related]
30. Solute fluxes in different treatment modalities.
Leypoldt JK
Nephrol Dial Transplant; 2000; 15 Suppl 1():3-9. PubMed ID: 10737159
[TBL] [Abstract][Full Text] [Related]
31. Biocompatibility evaluation of polyamide hemofiltration.
Panichi V; Bianchi AM; Andreini B; Casarosa L; Migliori M; De Pietro S; Taccola D; Giovannini L; Palla R
Int J Artif Organs; 1998 Jul; 21(7):408-13. PubMed ID: 9745996
[TBL] [Abstract][Full Text] [Related]
32. Clearance of beta-2-microglobulin and middle molecules in haemodiafiltration.
Tattersall J
Contrib Nephrol; 2007; 158():201-209. PubMed ID: 17684359
[TBL] [Abstract][Full Text] [Related]
33. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
[TBL] [Abstract][Full Text] [Related]
34. Optimization of mid-dilution haemodiafiltration: technique and performance.
Pedrini LA; Feliciani A; Zerbi S; Cozzi G; Ruggiero P
Nephrol Dial Transplant; 2009 Sep; 24(9):2816-24. PubMed ID: 19420103
[TBL] [Abstract][Full Text] [Related]
35. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
36. The contribution of hemofiltration among the treatment modalities of chronic uremia.
Vidi E; Bianco F; Panzetta G
Int J Artif Organs; 1993 Dec; 16(12):809-15. PubMed ID: 8175195
[TBL] [Abstract][Full Text] [Related]
37. Rebound kinetics of beta2-microglobulin after hemodialysis.
Leypoldt JK; Cheung AK; Deeter RB
Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
[TBL] [Abstract][Full Text] [Related]
38. Computational assessment of the effects of a pulsatile pump on toxin removal in blood purification.
Lim KM; Shim EB
Biomed Eng Online; 2010 Jun; 9():31. PubMed ID: 20569462
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Fox SD; Henderson LW
Blood Purif; 1993; 11(4):224-36. PubMed ID: 8297564
[TBL] [Abstract][Full Text] [Related]
40. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
